Cargando…
Ex vivo explant model of adenoma and colorectal cancer to explore mechanisms of action and patient response to cancer prevention therapies
Colorectal cancer (CRC) is the second leading cause of cancer death in the UK. Novel therapeutic prevention strategies to inhibit the development and progression of CRC would be invaluable. Potential contenders include low toxicity agents such as dietary-derived agents or repurposed drugs. However,...
Autores principales: | Khan, Sam, Miles, Gareth J, Demetriou, Constantinos, Sidat, Zahirah, Foreman, Nalini, West, Kevin, Karmokar, Ankur, Howells, Lynne, Pritchard, Catrin, Thomas, Anne L, Brown, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730503/ https://www.ncbi.nlm.nih.gov/pubmed/36426854 http://dx.doi.org/10.1093/mutage/geac020 |
Ejemplares similares
-
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery
por: Powley, Ian R., et al.
Publicado: (2020) -
Evaluating and comparing immunostaining and computational methods for spatial profiling of drug response in patient-derived explants
por: Miles, Gareth J, et al.
Publicado: (2021) -
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial
por: Howells, Lynne M, et al.
Publicado: (2019) -
Outcome of a novel modified endoscopic papillectomy for duodenal major papilla adenoma
por: Wang, Pin, et al.
Publicado: (2020) -
Phospholipid dynamics in ex vivo lung cancer and normal lung explants
por: Lesko, Julia, et al.
Publicado: (2021)